Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000725169 | SCV000237893 | likely benign | not provided | 2021-04-01 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000213403 | SCV000272823 | uncertain significance | not specified | 2016-01-11 | criteria provided, single submitter | clinical testing | The p.Cys31268Ser variant in TTN has not been previously reported in individuals with cardiomyopathy, but has been identified in 11/16510 South Asian and 5/6672 4 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.br oadinstitute.org; dbSNP rs766439271). Computational prediction tools and conserv ation analysis do not provide strong support for or against an impact to the pro tein. In summary, the clinical significance of the p.Cys31268Ser variant is unce rtain. |
Eurofins Ntd Llc |
RCV000725169 | SCV000334607 | uncertain significance | not provided | 2017-11-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000535734 | SCV000642509 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-08-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002381618 | SCV002671656 | likely benign | Cardiovascular phenotype | 2019-10-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |